Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Apple
AAPL
|
+$953M |
| 2 |
NVIDIA
NVDA
|
+$784M |
| 3 |
Meta Platforms (Facebook)
META
|
+$753M |
| 4 |
Berkshire Hathaway Class A
BRK.A
|
+$316M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$315M |
Top Sells
| 1 |
Amazon
AMZN
|
+$1.17B |
| 2 |
UnitedHealth
UNH
|
+$686M |
| 3 |
Tesla
TSLA
|
+$506M |
| 4 |
Abbott
ABT
|
+$388M |
| 5 |
Johnson & Johnson
JNJ
|
+$325M |
Sector Composition
| 1 | Technology | 20.29% |
| 2 | Healthcare | 16.94% |
| 3 | Consumer Discretionary | 12.83% |
| 4 | Consumer Staples | 9.16% |
| 5 | Industrials | 9.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2526
Invesco S&P 500 Top 50 ETF
XLG
$10.6B
| $909K | ﹤0.01% |
+26,000
| New | +$909K |
|
2527
Barnwell Industries
BRN
$11.8M
| $908K | ﹤0.01% |
356,222
-27,800
| -7% | -$70.9K |
|
2528
OptimizeRx
OPRX
$330M
| $907K | ﹤0.01% |
63,500
-120,900
| -66% | -$1.73M |
|
2529
Schwab US Large- Cap ETF
SCHX
$60.3B
| $906K | ﹤0.01% |
+51,900
| New | +$906K |
|
2530
First US Bancshares
FUSB
$73.1M
| $905K | ﹤0.01% |
105,821
-900
| -0.8% | -$7.7K |
|
2531
Equity Lifestyle Properties
ELS
$11.7B
| $904K | ﹤0.01% |
+13,519
| New | +$904K |
|
2532
Ultragenyx Pharmaceutical
RARE
$2.77B
| $904K | ﹤0.01% |
+19,600
| New | +$904K |
|
2533
Precision BioSciences
DTIL
$53.4M
| $903K | ﹤0.01% |
57,222
+6,344
| +12% | +$100K |
|
|
ITI
2534
DELISTED
Iteris, Inc.
ITI
| $902K | ﹤0.01% |
227,685
-19,175
| -8% | -$76K |
|
2535
Vanguard FTSE Pacific ETF
VPL
$8.04B
| $899K | ﹤0.01% |
12,900
-36,400
| -74% | -$2.54M |
|
2536
Minerva Neurosciences
NERV
$15M
| $898K | ﹤0.01% |
98,300
-12,500
| -11% | -$114K |
|
|
FOCS
2537
DELISTED
Focus Financial Partners Inc. Class A
FOCS
| $898K | ﹤0.01% |
17,100
-36,200
| -68% | -$1.9M |
|
2538
Vanguard Long-Term Corporate Bond ETF
VCLT
$7.46B
| $895K | ﹤0.01% |
+11,400
| New | +$895K |
|
2539
Carisma Therapeutics
CARM
$13.1M
| $892K | ﹤0.01% |
101,760
+33,465
| +49% | +$293K |
|
2540
SkyWater Technology
SKYT
$594M
| $892K | ﹤0.01% |
94,700
-9,567
| -9% | -$90.1K |
|
2541
Ponce Financial Group
PDLB
$336M
| $891K | ﹤0.01% |
102,494
-8,100
| -7% | -$70.4K |
|
2542
Spruce Power Holding Corp
SPRU
$31.4M
| $891K | ﹤0.01% |
137,225
+2,787
| +2% | +$18.1K |
|
2543
Direxion Daily 20+ Year Treasury Bear 3X Shares
TMV
$181M
| $891K | ﹤0.01% |
+30,800
| New | +$891K |
|
2544
Virco
VIRC
$124M
| $890K | ﹤0.01% |
213,364
+14,034
| +7% | +$58.5K |
|
2545
Xoma
XOMA
$444M
| $890K | ﹤0.01% |
47,100
+35,499
| +306% | +$671K |
|
2546
ZimVie
ZIMV
$533M
| $885K | ﹤0.01% |
78,800
-19,311
| -20% | -$217K |
|
|
ASM
2547
Avino Silver & Gold Mines
ASM
$643M
| $884K | ﹤0.01% |
1,339,500
+436,400
| +48% | +$288K |
|
2548
Bakkt Holdings
BKKT
$154M
| $884K | ﹤0.01% |
28,764
+7,356
| +34% | +$226K |
|
2549
Larimar Therapeutics
LRMR
$349M
| $881K | ﹤0.01% |
281,574
+98,832
| +54% | +$309K |
|
2550
Trio-Tech International
TRT
$22.1M
| $880K | ﹤0.01% |
182,863
-4,283
| -2% | -$20.6K |
|